Impact of Heart Failure Severity on Vutrisiran Efficacy in Transthyretin Amyloidosis with Cardiomyopathy

Maurer, M. S., Witteles, R. M., Garcia-Pavia, P., Sheikh, F. H., Morbach, C., Rodriguez Duque, D., Aldinc, E., Eraly, S. A., & Gillmore, J. D. (2025). Impact of Heart Failure Severity on Vutrisiran Efficacy in Transthyretin Amyloidosis with Cardiomyopathy. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2025.03.477
Authors:
Mathew S Maurer
Ronald M Witteles
Pablo Garcia-Pavia
Farooq H Sheikh
Caroline Morbach
Daniel Rodriguez Duque
Emre Aldinc
Satish A Eraly
Julian D Gillmore
Affiliated Authors:
Mathew S Maurer
Author Keywords:
attr
cardiac
heart failure
physical functioning
Publication Type:
Article
Unique ID:
10.1016/j.jacc.2025.03.477
PMID:
Publication Date:
Data Source:
PubMed

Record Created: